LEPR and breast carcinoma: For example, in a model of 4T1 mammary carcinoma cells grown adjacent to the mammary fat pad of syngeneic mice (85), leptin receptor antagonists reduced tumor growth by up to 90% and this was associated with reduced VEGF and VEGFR tumor expression.